KAUST researchers are exploring the link between nutrition and brain-energy metabolism to address cognitive decline, dementia, and Alzheimer’s disease. Dr. Pierre Magistretti and Dr. Johannes le Coutre are collaborating on ways to merge brain-energy metabolism research into the field of nutrition. They published an article entitled “Goals in Nutrition Science 2015-2020” in the journal Frontiers in Nutrition. Why it matters: This research could lead to nutritional interventions to hinder or prevent cognitive decline, offering a new approach beyond traditional drug treatments.
MBZUAI researchers developed ClinGRAD, a multimodal graph neural network that analyzes genomic data, MRI scans, and clinical information to classify dementia types (Alzheimer's, vascular, etc.). The system addresses the challenge of high misdiagnosis rates (up to 30%) in dementia, where incorrect diagnoses can significantly impact patient life expectancy. ClinGRAD aims to be an interpretable AI system, providing explainability to clinicians. Why it matters: Accurate and early diagnosis of dementia subtypes is crucial for slowing disease progression and improving patient care in the region, where the prevalence of dementia is expected to rise significantly.
MBZUAI valedictorian Salma Hassan developed a multimodal graph learning approach for early dementia diagnosis and prognosis. Her master's thesis focused on differential diagnosis to identify specific dementia subtypes and predicting cognitive decline in preclinical patients. The AI model leverages brain imaging, genetics, and clinical records to improve diagnostic accuracy. Why it matters: This research can improve early detection and resource allocation for dementia management, especially in developing countries.
Dr. Yves Agid from the ICM Paris Institute of Translational Neuroscience lectured at KAUST's 2018 Winter Enrichment Program about the role of glial cells in brain function and behavior. He highlighted that glial cells, often overlooked in research, are crucial for neural synchronization and overall intelligence. Dysfunction of glial cells can induce pathologies like Alzheimer's and Parkinson's disease. Why it matters: The lecture underscored the importance of studying glial cells in addition to neurons for understanding and treating neurodegenerative disorders, which could influence future research directions at KAUST and in the region.
A Caltech researcher presented at MBZUAI on memory representation and retrieval, contrasting AI and neuroscience approaches. Current AI retrieval systems like RAG retrieve via fine-tuning and embedding similarity, while the presenter argued for exploring retrieval via combinatorial object identity or spatial proximity. The research explores circuit-level retrieval via domain fine-tuned LLMs and distributed memory for image retrieval using semantic similarity. Why it matters: The work suggests structured databases and retrieval-focused training can allow smaller models to outperform larger general-purpose models, offering efficiency gains for AI development in the region.
Tom M. Mitchell from Carnegie Mellon University discussed using machine learning to study how the brain processes natural language, using fMRI and MEG to record brain activity while reading text. The research explores neural encodings of word meaning, information flow during word comprehension, and how meanings of words combine in sentences and stories. He also touched on how understanding of the brain aligns with current AI approaches to NLP. Why it matters: This interdisciplinary research could bridge the gap between neuroscience and AI, potentially leading to more human-like NLP models.
MBZUAI Professor Fakherddine Karray is developing deep learning algorithms for human activity recognition to monitor the health and safety of elderly people. The AI tools analyze movement, posture, and facial expressions to detect early warning signs of health emergencies. Remote patient monitoring systems integrate smart devices and secure communication to allow elderly patients to stay at home and communicate with healthcare providers. Why it matters: AI-powered smart homes can provide affordable healthcare solutions for the rapidly growing elderly population in the region and worldwide.
A senior lecturer at the University of New South Wales discussed the use of AI to improve early prognosis and personalized treatment plans for neurodegenerative diseases, cardiovascular imaging and multiomics. The lecture highlighted the potential of AI algorithms to detect subtle changes at early stages through advanced multiomics techniques and medical imaging analysis. The speaker has expertise in analyzing medical images and has collaborated with medical professionals to develop AI tools for diagnosis of cancer, neurodegenerative disease, and heart disease. Why it matters: AI-driven prognosis and treatment planning promises earlier intervention and improved outcomes for challenging diseases in the region.